angiotensin ii has been researched along with Endotoxin Shock in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (33.72) | 18.7374 |
1990's | 12 (13.95) | 18.2507 |
2000's | 6 (6.98) | 29.6817 |
2010's | 22 (25.58) | 24.3611 |
2020's | 17 (19.77) | 2.80 |
Authors | Studies |
---|---|
Balakumar, P; Jagadeesh, G; Senatore, F | 1 |
Bonderski, V; Krishnan, K; Rech, MA; Tednes, P; Wassermann, TB | 1 |
Machavariani, K; Pachkoria, E; Ratiani, L; Rurua, M; Sanikidze, T; Shoshiashvili, V | 1 |
Aydogan, MS; Baykan, S; Bicakcioglu, M; Bulut, N; Demircan, S; Dogan, Z; Duzenci, D; Ersoy, Y; Kalkan, S; Kibrislioglu Uysal, N; Korkmaz Disli, Z; Ozer, AB; Yucel, A; Yucel, N | 1 |
Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
Annoni, F; Creteur, J; Dewachter, L; Favory, R; Garcia, B; Herpain, A; Hubesch, G; Khaldi, A; Moiroux-Sahraoui, A; Njimi, H; Rocha-Oliveira, E; Roncon-Albuquerque, R; Su, F; Taccone, FS; Vasques-Nóvoa, F; Vincent, JL | 1 |
Baykan, S; Bicakcioglu, M; Bulut, N; Ersoy, Y; Kibrislioglu Uysal, N; Ozer, AB; Yucel, N | 1 |
Cecconi, M; Chew, MS; De Backer, D; Hajjar, L; Monnet, X; Ospina-Tascón, GA; Ostermann, M; Pinsky, MR; Vincent, JL | 1 |
Edinger, F; Koch, C; Markmann, M; Pitz, L; Sander, M; Schmidt, G; Schneck, E | 1 |
Ainsworth, CR; Chow, JH; Coleman, PJ; Kim, DE; Mazzeffi, MA; McCurdy, MT; Nissen, AP | 1 |
Evans, H; Ho, VP; Kaafarani, H; Namias, N; Rattan, R; Zakrison, TL | 1 |
Jansen, G; Morelli, A; Rehberg, S | 1 |
Chow, JH; Galvagno, SM; Heavner, MS; Mazzeffi, MA; McCurdy, MT; Tanaka, KA | 1 |
Azad, N; Bartlett, B; Chowdhury, A; Das, S; Jain, N; Khan, SA; Kolar, GJ; Subla, MR; Taji, J; Wang, H; Wieruszewski, PM | 1 |
Bui, AD; Guru, PK; Helgeson, SA; Sanghavi, DK | 1 |
Barth, RN; Chancer, Z; Chow, JH; LaMattina, JC; Lankford, AS; Mazzeffi, MA; McCurdy, MT; Scalea, JR; Wallis, M | 1 |
Boyd, JH; Gordon, AC; Kissoon, N; Russell, JA; Walley, KR; Williams, MD | 1 |
Belletti, A; Landoni, G | 1 |
Busse, LW; Hall, A; Ostermann, M | 1 |
Aschenbrenner, DS | 1 |
Chancer, Z; Chow, JH; Galvagno, SM; Henderson, R; Mazzeffi, MA; McCurdy, MT; Tanaka, KA | 1 |
Khanna, AK; Sacha, GL; Wakefield, BJ | 1 |
Baganha, F; Carneiro, F; Castro-Chaves, P; Cerqueira, RJ; Gonçalves, F; Heymans, S; Laundos, TL; Leite-Moreira, AF; Mendonça, L; Nascimento, DS; Paiva, JA; Pinto-do-Ó, P; Quina-Rodrigues, C; Reguenga, C; Ribeiro, S; Roncon-Albuquerque, R; Schroen, B; Soares-Dos-Reis, R; Vasques-Nóvoa, F; Verhesen, W | 1 |
Hariharan, S; Jagadeesh, G; Liu, Q; McDowell, TY; Pillai, VC; Rose, M; Sapru, MK; Senatore, F; Southworth, MR; Stockbridge, N | 1 |
Boldt, DW; Gunnerson, K; Harper, MD; Lim, GW; Ostermann, M | 1 |
Abril, MK; Busse, LW; Handisides, D; Khanna, AK; Kroll, S; McNamara, C | 1 |
Bitker, L; Burrell, LM | 1 |
Jadhav, AP; Sadaka, FG | 1 |
Fernandez, EM; Rodriguez, R | 1 |
Li, T; Liang, JL; Liu, LM; Yang, GM | 1 |
Corrêa, TD; Djafarzadeh, S; Jakob, SM; Jeger, V; Pereira, AJ; Takala, J | 1 |
Asfar, P; Chawla, L; Lerolle, N; Radermacher, P | 1 |
Alotaibi, Z; Brasha-Mitchell, E; Busse, L; Chawla, LS; Davison, D; Honiq, J; Seneff, MG | 1 |
Kimmoun, A; Levy, B | 1 |
Corrêa, TD; Jakob, SM; Takala, J | 1 |
Agosta, S; Annoni, F; Antonucci, E; Gleeson, PJ; Orlando, S; Scolletta, S; Taccone, FS; Velissaris, D | 1 |
Bellomo, R; Hilton, A | 1 |
Bellomo, R; Langenberg, C; May, CN; Wan, L | 1 |
De Backer, D; de Sousa, DB; He, X; Maciel, LK; Penaccini, L; Rocco, JR; Salgado, DR; Silva, E; Su, F; Taccone, F; Vincent, JL | 1 |
FINSTAD, J; MELBY, JC; SPINK, WW; VICK, JA | 1 |
Arendshorst, WJ; Boffa, JJ | 1 |
Duckworth, AJ; Goodship, AE; Kendall, HJ; Osborn, EC | 1 |
Chatziantoniou, C; Curat, CA; Dussaule, JC; Flamant, M; Placier, S; Rodenas, A; Vogel, WF | 1 |
Brackett, DJ; Wilson, MF | 1 |
Coakley, JH; Wray, GM | 1 |
Hartvig, T; Heslet, L; Jønsson, V; Ryding, J | 1 |
Chang, YZ; Dong, LW; Su, JY; Tang, CS; Tang, J; Tong, LJ | 1 |
Pittner, RA; Spitzer, JA | 1 |
Dunn, CW; Horton, JW | 1 |
Dade, JP; Whiteley, SM | 1 |
Morel, DR; Pastor, CM | 1 |
Dong, L; Ji, Y; Ren, X; Su, J; Wu, L; Zhao, Y | 1 |
Finkel, MS; Johnson, LA; Kan, H | 1 |
Cattier, B; Ferrandière, M; Hazouard, E; Lanotte, R; Moulias, S; Perrotin, D | 1 |
Petros, A; Yunge, M | 1 |
Boyle, WA; Kakihana, Y; Nakamura, M; Nakano, Y; Tsuneyoshi, I; Yamada, H | 1 |
Miyazaki, M; Yukioka, N | 1 |
Feldhaus, RA; Isakson, PC; McKnight, RC; Needleman, P; Raz, A; Shofer, F | 1 |
Hofstetter, A; Marx, FJ; Schilling, A | 1 |
Baker, CH; Dietz, JR; Sutton, ET | 1 |
Nielsen, MS; Thomas, VL | 1 |
Brunner, HR; Nussberger, J; Schaller, MD; Waeber, B | 1 |
Emerson, TE | 1 |
Kováts, TG | 1 |
Dohmen, M | 1 |
Emerson, TE; Hinshaw, LB; Reins, DA | 1 |
Downing, SE; Solis, RT | 1 |
Pagano, F; Tajoli, E; Verlato, R | 1 |
Fabian, M; Siegel, JH | 1 |
Gold, EM; Vaughn, DL; White, FN | 1 |
Assali, NS; Bersentes, T; Kirschbaum, TH; Vaughn, DL | 1 |
Rex, H | 1 |
Clauss, RH; Ray, JF | 1 |
Enderlin, F; Gigon, JP; Wolff, G | 1 |
Itskovitz, HD; Miller, L; Ural, W; White, R; Zapp, J | 1 |
Border, JR; Heyden, WC; Hopkinson, BR; Jacobs, RR; Schenk, WG | 1 |
Hall, RC; Hodge, RL | 1 |
Haack, DL; Miksche, LW; Seyberth, HW | 1 |
Haack, D; Miksche, L; Seyberth, HW | 1 |
Fronek, K; Zweifach, BW | 1 |
Habermann, E | 1 |
Beckman, CB; Dietzman, RH; Lillehei, RC; Romero, LH; Schultz, LS | 1 |
Emmanouel, DS; Katz, AI | 1 |
Errington, ML; Rocha e Silva, M | 1 |
Kovách, AG; Linke, PG | 1 |
20 review(s) available for angiotensin ii and Endotoxin Shock
Article | Year |
---|---|
Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management.
Topics: Angiotensin II; Animals; Humans; Renin-Angiotensin System; Shock, Septic | 2021 |
Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients.
Topics: Angiotensin II; Ascorbic Acid; Crystalloid Solutions; Disease Management; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hydrocortisone; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan; Thiamine | 2022 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
A plea for personalization of the hemodynamic management of septic shock.
Topics: Angiotensin II; Hemodynamic Monitoring; Hemodynamics; Humans; Lactates; Precision Medicine; Shock, Septic; Vasoconstrictor Agents | 2022 |
Sepsis 2019: What Surgeons Need to Know.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Duration of Therapy; Enterobacteriaceae Infections; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Methicillin-Resistant Staphylococcus aureus; Methylene Blue; Organ Dysfunction Scores; Patient Care Bundles; Postoperative Complications; Practice Guidelines as Topic; Procalcitonin; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Shock, Septic; Staphylococcal Infections; Thiamine; Vancomycin-Resistant Enterococci; Vasoconstrictor Agents; Vitamin B Complex | 2020 |
Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
Topics: Angiotensin II; Catecholamines; Humans; Hypotension; Shock, Septic; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2021 |
Angiotensin II increases blood pressure in patients with refractory vasodilatory shock.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Blood Pressure Determination; Hemodynamics; Humans; Shock; Shock, Septic; Vasoconstrictor Agents; Vasodilation | 2018 |
Angiotensin in Critical Care.
Topics: Angiotensin II; Angiotensins; Critical Care; Humans; Hypotension; Shock, Septic; Vasoconstrictor Agents | 2018 |
Vasodilatory shock in the ICU and the role of angiotensin II.
Topics: Angiotensin II; Blood Pressure; Blood Pressure Determination; Humans; Intensive Care Units; Monitoring, Physiologic; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2018 |
Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiotensin I; Angiotensin II; Blood Pressure; Critical Illness; Female; Homeostasis; Humans; Male; Middle Aged; Peptide Fragments; Renin-Angiotensin System; Respiratory Distress Syndrome; Shock, Septic; Vasoconstrictor Agents | 2019 |
Angiotensin II in septic shock.
Topics: Angiotensin II; Catecholamines; Humans; Randomized Controlled Trials as Topic; Shock, Septic; Vasoconstrictor Agents | 2019 |
Role of angiotensin II in treatment of refractory distributive shock.
Topics: Administration, Intravenous; Angiotensin II; Blood Pressure; Humans; Hypotension; Regional Blood Flow; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2019 |
Angiotensin II in septic shock.
Topics: Angiotensin II; Critical Care; Humans; Renin-Angiotensin System; Shock, Septic; Vasoconstrictor Agents | 2015 |
Angiotensin II in Refractory Septic Shock.
Topics: Angiotensin II; Hemodynamics; Humans; Shock, Septic; Vasoconstrictor Agents | 2017 |
Fighting fire with fire.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalaprilat; Endothelium, Vascular; Heart Failure; Humans; Renin; Shock, Septic | 1998 |
Participation of endogenous vasoactive agents in the pathogenesis of endotoxin shock.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Catecholamines; Central Nervous System; Electrolytes; Histamine Release; Humans; Lysosomes; Peptides; Prostaglandins; Serotonin; Shock, Septic; Vascular Resistance; Vasomotor System | 1971 |
[The importance of angiotensin in clinical practice].
Topics: Aldosterone; Anaphylaxis; Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rate; Humans; Hypertension; Mitral Valve Stenosis; Shock, Septic; Shock, Surgical | 1966 |
Pharmacologic assistance to the failing circulation.
Topics: Adenosine Triphosphatases; Aminophylline; Angiotensin II; Blood Gas Analysis; Blood Pressure; Cardiac Output; Chlorpromazine; Digitalis Glycosides; Heart Failure; Humans; Myocardial Infarction; Phenoxybenzamine; Pulmonary Edema; Shock, Hemorrhagic; Shock, Septic; Sympatholytics; Sympathomimetics; Vascular Resistance; Water-Electrolyte Balance | 1968 |
[Mediators in shock processes: pathogenetic and therapeutic problems].
Topics: Acetylcholine; Adrenal Cortex Hormones; Anaphylaxis; Angiotensin II; Animals; Blood Vessels; Cell Membrane Permeability; Complement System Proteins; Dogs; Endotoxins; Haplorhini; Histamine; Humans; Kinins; Norepinephrine; Phospholipases; Rabbits; Serotonin; Shock; Shock, Hemorrhagic; Shock, Septic; Trypsin | 1971 |
Acute renal failure in obstetric septic shock. Current views on pathogenesis and management.
Topics: Abortion, Septic; Acute Kidney Injury; Analgesics; Angiotensin II; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Catecholamines; Digoxin; Disseminated Intravascular Coagulation; Diuretics; Dogs; Female; Hemodynamics; Humans; Hypnotics and Sedatives; Hypotension; Kidney; Kidney Concentrating Ability; Kidney Cortex Necrosis; Pregnancy; Pregnancy Complications, Infectious; Prostaglandins; Rabbits; Renal Dialysis; Renin; Sepsis; Shock, Septic; Sympathetic Nervous System; Tranquilizing Agents; Water-Electrolyte Balance | 1973 |
3 trial(s) available for angiotensin ii and Endotoxin Shock
Article | Year |
---|---|
FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Blood Pressure; Cardiovascular System; Double-Blind Method; Female; Humans; Hypotension; Male; Middle Aged; Shock, Septic; Treatment Outcome; United States; United States Food and Drug Administration; Vasoconstrictor Agents; Young Adult | 2019 |
Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
Topics: Administration, Intravenous; Aged; Angiotensin II; Blood Pressure; Cardiac Output; Catecholamines; Female; Humans; Male; Middle Aged; Norepinephrine; Pilot Projects; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2014 |
Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Gas Analysis; Blood Glucose; Critical Illness; Drug Monitoring; Electrolytes; Female; Hemodynamics; Humans; Infusions, Intravenous; Lactic Acid; Male; Middle Aged; Prospective Studies; Renin; Shock, Septic; Survival Analysis; Time Factors; Vasoconstrictor Agents; Vasopressins | 2001 |
63 other study(ies) available for angiotensin ii and Endotoxin Shock
Article | Year |
---|---|
THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW).
Topics: Angiotensin II; Humans; Multiple Organ Failure; Shock, Septic; Vasoconstrictor Agents; Vasodilation | 2022 |
Angiotensin II and angiotensin II receptor 2 levels can predict shock and mortality in septic patients.
Topics: Angiotensin II; Humans; Prognosis; Receptors, Angiotensin; Sepsis; Shock, Septic | 2022 |
Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock.
Topics: Angiotensin II; Animals; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Myocardium; Norepinephrine; Receptors, Interleukin-1; RNA, Messenger; Shock, Septic; Swine | 2022 |
Hydrocortisone may act through the angiotensin II receptor-2 level in patients with catecholamine-resistant septic shock.
Topics: Angiotensin II; Catecholamines; Humans; Hydrocortisone; Sepsis; Shock, Septic | 2023 |
Micro-lightguide spectrophotometry assessment of hepatic and intestinal microcirculation in endotoxemic rats during intravenous treatment with angiotensin II.
Topics: Angiotensin II; Animals; Endotoxemia; Hemodynamics; Male; Microcirculation; Rats; Rats, Inbred Lew; Shock, Septic | 2023 |
Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
Topics: Angiotensin II; Humans; Liver Cirrhosis; Male; Middle Aged; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2020 |
Selepressin for Patients With Septic Shock.
Topics: Angiotensin II; Humans; Shock; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2020 |
Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock.
Topics: Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Male; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2; Shock, Septic | 2020 |
Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia.
Topics: Aged; Angiotensin II; Antineoplastic Agents; Humans; Lung; Male; Neutropenia; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Radiography, Thoracic; Shock, Septic; Vasoconstrictor Agents | 2020 |
Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock.
Topics: Angiotensin II; Female; Humans; Male; Middle Aged; Renin; Renin-Angiotensin System; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2021 |
Vasopressor Therapy in the Intensive Care Unit.
Topics: Angiotensin II; Dopamine; Epinephrine; Humans; Intensive Care Units; Norepinephrine; Shock; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2021 |
New Hypotension Treatment for Septic Shock.
Topics: Administration, Intravenous; Angiotensin II; Drug Approval; Humans; Hypotension; Shock, Septic; Vasoconstrictor Agents | 2018 |
When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report.
Topics: Aged; Angiotensin II; Escherichia coli; Escherichia coli Infections; Humans; Intestinal Perforation; Male; Shock, Septic; Streptococcal Infections; Streptococcus anginosus; Treatment Outcome; Vasoplegia | 2018 |
MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock.
Topics: Angiotensin II; Animals; Blood Vessels; Cells, Cultured; Cyclic GMP; Endothelial Cells; Heart; Humans; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Nitric Oxide; Prospective Studies; Random Allocation; Shock, Septic; Signal Transduction | 2018 |
Angiotensin in ECMO patients with refractory shock.
Topics: Adult; Angiotensin II; Angiotensins; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Middle Aged; Shock; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2018 |
Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiotensin II; Australia; Canada; Chi-Square Distribution; Europe; Female; Humans; Male; Middle Aged; Neurophysins; Norepinephrine; Prospective Studies; Protein Precursors; Retrospective Studies; Shock; Shock, Septic; United States; Vasoconstrictor Agents; Vasopressins; Young Adult | 2019 |
Angiotensin II (Giapreza) for septic shock.
Topics: Angiotensin II; Drug Interactions; Humans; Renin-Angiotensin System; Shock, Septic; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents | 2018 |
Effects of interleukin-1β on vascular reactivity after lipopolysaccharide-induced endotoxic shock in rabbits and its relationship with PKC and Rho kinase.
Topics: Amides; Angiotensin II; Animals; Arterial Pressure; Blood Vessels; Calcium Signaling; Humans; Interleukin-1beta; Lipopolysaccharides; Mesenteric Arteries; Phosphorylation; Protein Kinase C; Pyridines; Rabbits; Recombinant Proteins; rho-Associated Kinases; Shock, Septic; Tetradecanoylphorbol Acetate | 2013 |
Angiotensin II in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cell Respiration; Disease Models, Animal; Dose-Response Relationship, Drug; Fluid Therapy; Hemodynamics; Hypotension; Male; Mitochondria; Norepinephrine; Peritonitis; Random Allocation; Renin-Angiotensin System; Shock, Septic; Swine; Vasoconstrictor Agents | 2014 |
Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*.
Topics: Angiotensin II; Animals; Hypotension; Male; Norepinephrine; Peritonitis; Shock, Septic; Vasoconstrictor Agents | 2014 |
Angiotensin II: a new approach for refractory shock management?
Topics: Angiotensin II; Female; Humans; Male; Norepinephrine; Shock, Septic; Vasoconstrictor Agents | 2014 |
The ATHOS-3 trial, angiotensin II and The Three Musketeers.
Topics: Angiotensin II; Humans; Hypotension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Shock, Septic; Vasoconstrictor Agents | 2017 |
Angiotensin II in experimental hyperdynamic sepsis.
Topics: Angiotensin II; Animals; Creatinine; Diuresis; Escherichia coli Infections; Female; Hemodynamics; Renal Circulation; Sepsis; Sheep; Shock, Septic | 2009 |
Sublingual microcirculatory effects of enalaprilat in an ovine model of septic shock.
Topics: Angiotensin II; Animals; Enalaprilat; Female; Fluid Therapy; Microcirculation; Mouth Floor; Placebos; Random Allocation; Sheep, Domestic; Shock, Septic | 2011 |
Influence of aldosterone and angiotensin II on endotoxin shock in the primate.
Topics: Aldosterone; Angiotensin II; Animals; Endotoxins; Humans; Hypertension; Primates; Shock; Shock, Septic | 1963 |
Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Arginine Vasopressin; Enzyme Inhibitors; Glomerular Filtration Rate; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Renal Circulation; Shock, Septic; Urine; Vasoconstrictor Agents | 2005 |
Pressor and intra-renal effects of angiotensins I and II, and noradrenaline, in anaesthetized and conscious sheep. The effects of halothane anaesthesia on pressor sensitivity and electrolyte shifts: the proposed use of angiotensin I in treating septicaemi
Topics: Angiotensin I; Angiotensin II; Animals; Electrolytes; Halothane; Kidney; Norepinephrine; Sepsis; Sheep; Shock, Septic | 2005 |
Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease.
Topics: Angiotensin II; Animals; Chemokine CCL2; Collagen Type I; Collagen Type IV; Cytokines; Discoidin Domain Receptors; Disease Models, Animal; Fibrosis; Hypertension; Inflammation; Kidney Failure, Chronic; Kidney Glomerulus; Lipopolysaccharides; Male; Mice; Mice, Transgenic; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Shock, Septic; Vasoconstrictor Agents | 2006 |
Release of vasoactive hormones and circulatory changes in shock.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Endorphins; Epoprostenol; Hemodynamics; Histamine; Hormones; Humans; Shock, Septic; Thromboxanes; Vasoconstriction; Vasodilation; Vasopressins | 1983 |
Severe septic shock unresponsive to noradrenaline.
Topics: Adult; Angiotensin II; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hemodynamics; Humans; Norepinephrine; Peritonitis; Puerperal Infection; Shock, Septic; Treatment Failure; Vasoconstrictor Agents | 1995 |
Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient.
Topics: Amrinone; Angiotensin II; Doxorubicin; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Middle Aged; Myocardial Contraction; Shock, Septic | 1995 |
Role of regulatory peptide in pathogenesis of shock.
Topics: Angiotensin II; Animals; Blood Glucose; Blood Pressure; Calcitonin Gene-Related Peptide; Endothelins; Immunization, Passive; Liver; Male; Myocardium; Rats; Rats, Wistar; Shock, Septic | 1994 |
Shift from alpha- to beta-type adrenergic receptor-mediated responses in chronically endotoxemic rats.
Topics: Angiotensin II; Animals; Cells, Cultured; Chlorides; Endotoxins; Escherichia coli; Glucagon; Inositol Phosphates; Kinetics; Lithium; Lithium Chloride; Liver; Male; Norepinephrine; Phosphorylase a; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Shock, Septic; Vasopressins | 1993 |
Role of angiotensin II in neonatal sepsis.
Topics: Angiotensin II; Animals; Animals, Newborn; Captopril; Dogs; Epoprostenol; Escherichia coli; Hemodynamics; Indomethacin; Lipopolysaccharides; Renin; Shock, Septic; Thromboxane B2 | 1993 |
Treatment of hypotension in septic shock.
Topics: Adolescent; Adult; Aged; Angiotensin II; Hemodynamics; Humans; Middle Aged; Norepinephrine; Shock, Septic; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vasoconstrictor Agents | 1996 |
Treatment of hypotension in septic shock.
Topics: Angiotensin II; Hemodynamics; Humans; Norepinephrine; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 1996 |
Role of intracardiac angiotensin II in cardiac dysfunction of rat during septic shock.
Topics: Angiotensin II; Animals; Cardiac Output, Low; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Shock, Septic | 1996 |
[Refractory Pasteurella multocida septic shock after inoculation: implications of angiotensin II inhibitors].
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bites and Stings; Cats; Fatal Outcome; Female; Hemodynamics; Humans; Pasteurella Infections; Pasteurella multocida; Shock, Septic | 1998 |
Angiotensin for septic shock unresponsive to noradrenaline.
Topics: Angiotensin II; Child, Preschool; Escherichia coli Infections; Humans; Male; Meningococcal Infections; Norepinephrine; Shock, Septic; Treatment Failure; Vasoconstrictor Agents | 2000 |
Renal blood flow in various types of hypotension and shock in dogs and men (preliminary report).
Topics: Angiotensin II; Animals; Catecholamines; Dogs; Hemodynamics; Humans; Hypotension, Controlled; Kidney; Regional Blood Flow; Renin; Shock; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic | 1978 |
Prostaglandins and the renin-angiotensin system in canine endotoxemia.
Topics: Angiotensin II; Animals; Disease Models, Animal; Dogs; Female; Hemodynamics; Indomethacin; Kidney; Male; Mesentery; Prostaglandins; Renin; Shock, Septic; Time Factors; Vascular Resistance | 1977 |
[Septic shock in the uroseptic patient. I. General and specific pathomechanisms of the septic shock (author's transl)].
Topics: Angiotensin II; Blood Coagulation; Blood Viscosity; Cardiac Output; Humans; Microcirculation; Oxygen Consumption; Renin; Shock, Septic | 1977 |
Endotoxin alteration of muscle microvascular renin-angiotensin responses.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Endotoxins; Male; Muscles; Rats; Rats, Inbred Strains; Renin; Saralasin; Shock, Septic; Vasoconstriction; Venules | 1992 |
Administration of angiotensin II in refractory septic shock.
Topics: Adult; Angiotensin II; Combined Modality Therapy; Critical Care; Drug Therapy, Combination; Female; Hemodynamics; Humans; Pneumococcal Infections; Sepsis; Shock, Septic | 1991 |
Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Endotoxins; Epinephrine; Male; Norepinephrine; Pentobarbital; Prazosin; Rats; Rats, Inbred Strains; Renin; Shock, Septic; Sympathetic Nervous System; Vasopressins | 1985 |
The role of targets and mediators in endotoxin shock.
Topics: Angiotensin II; Animals; Blood Coagulation; Bradykinin; Catecholamines; Endotoxins; Hemodynamics; Histamine Release; Humans; Leukocytosis; Microcirculation; Receptors, Adrenergic; Shock, Septic; Time Factors; Vasomotor System | 1971 |
[Shock treatment in the severely injured].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Angiotensin II; Blood Pressure; Blood Transfusion; Cardiac Glycosides; Central Venous Pressure; Ergoloid Mesylates; Germany, West; Heparin; Humans; Iatrogenic Disease; Infusions, Parenteral; Intensive Care Units; Norepinephrine; Oxygen Consumption; Pulse; Shock, Hemorrhagic; Shock, Septic; Shock, Traumatic; Streptokinase | 1971 |
Cardiovascular responses of the primate in endotoxin shock.
Topics: Angiotensin II; Animals; Endotoxins; Haplorhini; Hemodynamics; Hypotension; Primates; Shock, Septic | 1966 |
Effects of E. coli endotoxemia on ventricular performance.
Topics: Angiotensin II; Animals; Cats; Endotoxins; Escherichia coli Infections; Heart; Heart Ventricles; Histamine; Serotonin; Shock, Septic | 1966 |
[Prevention of acute renal insufficiency in toxinfective shock treated with sympathomimetic amines. Experimental and clinical findings].
Topics: Acute Kidney Injury; Aged; Angiotensin II; Humans; Male; Mannitol; Middle Aged; Shock, Septic; Sympathomimetics | 1965 |
Therapeutic advantages of an inotropic vasodilator in endotoxin shock.
Topics: Angiotensin II; Animals; Dogs; Escherichia coli; Heart; Isoproterenol; Methoxamine; Norepinephrine; Pressoreceptors; Renal Artery; Shock, Septic; Strophanthins; Vascular Resistance | 1967 |
Renin-aldosterone system in endotoxin shock in the dog.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Blood Pressure; Corticosterone; Dogs; Endotoxins; Escherichia coli; Hydrocortisone; Kidney; Nephrectomy; Pituitary Gland; Regional Blood Flow; Renin; Secretory Rate; Shock, Septic | 1967 |
Homeostatic role of the renal-adrenal axis in bacteremic shock. Its therapeutic implications.
Topics: Adrenal Cortex Hormones; Aldosterone; Angiotensin II; Animals; Dogs; Endotoxins; Homeostasis; Methylprednisolone; Renin; Shock, Septic | 1967 |
[The treatment of shock with isoproterenol].
Topics: Adult; Aged; Angiotensin II; Blood Circulation; Female; Humans; Isoproterenol; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Pulmonary Embolism; Shock; Shock, Hemorrhagic; Shock, Septic | 1966 |
Inactivation of angiotensin in shock.
Topics: Aminocaproates; Angiotensin II; Animals; Blood Pressure; Chromatography, Thin Layer; Diazoxide; Dogs; Hemolysis; Ischemia; Methods; Peptide Hydrolases; Shock, Hemorrhagic; Shock, Septic | 1969 |
The microcirculatory effects of endotoxin shock as evaluated by effects on interstitial fluid pressure.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Body Fluids; Central Venous Pressure; Disease Models, Animal; Dogs; Epinephrine; Methylprednisolone; Microcirculation; Norepinephrine; Phenoxybenzamine; Shock, Septic; Splenectomy | 1970 |
Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs.
Topics: Adrenal Glands; Angiotensin II; Animals; Blood Pressure; Catecholamines; Cats; Central Venous Pressure; Colon; Dogs; Electric Stimulation; Endotoxins; Entamoeba; Epinephrine; Female; Male; Muscle Contraction; Propranolol; Renin; Shock, Septic; Species Specificity; Stomach; Sympathetic Nervous System | 1971 |
[Activity of the renin-angiotensin system in entotoxin shock and during orthostatic loading of rabbits under corticosteroid therapy].
Topics: Angiotensin II; Animals; Hypotension, Orthostatic; Methylprednisolone; Rabbits; Renin; Shock, Septic | 1970 |
[Influence of methylprednisolone on the renin-angiotensin-system in endotoxin and orthostatic shock in the rabbit].
Topics: Angiotensin II; Animals; Hypotension, Orthostatic; Kidney; Methylprednisolone; Rabbits; Renin; Shock, Septic | 1971 |
Cardiovascular responses to bacterial endotoxin in anesthetized and nonanesthetized animals.
Topics: Anesthesia; Angiotensin II; Animals; Arteries; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cardiovascular System; Central Venous Pressure; Endotoxins; Escherichia coli; Mesenteric Arteries; Pentobarbital; Pressoreceptors; Rabbits; Salmonella; Shock, Septic; Vascular Resistance | 1972 |
Effects of blunted sympathetic nervous system response on regional tissue perfusion in experimental endotoxic shock.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Vessels; Dogs; Electric Stimulation; Epinephrine; Intestines; Kidney; Lactates; Norepinephrine; Oxygen Consumption; Radioisotopes; Regional Blood Flow; Shock, Septic; Sympathectomy; Sympathetic Nervous System; Vascular Resistance; Xenon | 1973 |
On the role of vasopressin and angiotensin in the development of irreversible haemorrhagic shock.
Topics: Angiotensin II; Animals; Blood Pressure; Blood Volume; Cardiac Output; Diabetes Insipidus; Dogs; Heart Rate; Intestines; Kidney; Liver; Male; Oligopeptides; Peptides; Shock, Hemorrhagic; Shock, Septic; Stomach; Vasopressins | 1974 |
[Experimental models for circulatory failure in hyperthermia under conditions of septic shock. Pressor reactions at various temperatures].
Topics: Angiotensin II; Animals; Blood Pressure; Dogs; Electric Stimulation; Epinephrine; Fever; Hypoxia; Isoproterenol; Models, Biological; Norepinephrine; Shock, Septic | 1974 |